Skip to content

Comparison of efficacy of two ayurveda drugs namely Truptighna dadhemani tablet and Nisha Amalaki churna in the management of Type 2 Diabetes mellitus

A comparative clinical study to evaluate the effectiveness of Truptighna dashemani and nisha amalaki churna in the management of prameha w.s.r. to type 2 diabetes mellitus - Nill

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088739
Enrollment
40
Registered
2025-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Shree swaminarayan ayurvedic college kalol
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients of age 25 to 60 years 2.urine glucose level maximum 250mg/dl 3.blood glucose level maximum 300mg/dl 4.the patients presenting with the classical signs and symptoms like prameha according to Ayurveda and Type 2 diabetes mellitus according to modern science will be taken.

Exclusion criteria

Exclusion criteria: 1.patients below 25years and above 60years of age 2.urine glucose level more than 250mg/dl 3.blood glucose level more than 300mg/dl 4.pregnant lady 5.totally and partially insulin dependent patients 6.serious systemic illness like Diabetes insipidus, chronic kidney disease, ischemic heart disease, autoimmune and endocrine disease,metabolic syndrome etc.

Design outcomes

Primary

MeasureTime frame
Efficacy of Truptighna dashemani tablet in prameha(Type 2 diabetes mellitus)Timepoint: 1 month

Secondary

MeasureTime frame
Efficacy of Nisha -Amalaki churna in prameha(Type 2 diabetes mellitus)Timepoint: 1 month

Countries

India

Contacts

Public ContactDr Vishal Solanki

Shree swaminarayan ayurvedic college kalol

vdtapankumar@gmail.com9924304388

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026